Tag: cultivation

While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience—now joined by UFO MAX and UFO in the top 3

THCA Vapes Dominate Premium Cannabis Market as Area 52 Named Best THCA Vape of 2025

VANCOUVER, British Columbia, July 04, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is pleased to confirm that further to its news release dated July 2, 2025, the Company has filed on SEDAR+ its audited financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the year ended February 28, 2025 (the “Annual Filings”). The Annual Filings can be obtained on the Company’s SEDAR+ profile at www.sedarplus.ca.

According to Towards FnB, the global vegan food market size is valued at USD 22.38 billion in 2025 to an impressive USD 55.88 billion by 2034, growing at a robust CAGR of 10.7% during the forecast period from 2025 to 2034. This significant growth is driven by rising consumer demand for plant-based alternatives, increasing health consciousness, and expanding vegan product offerings across mainstream retail and foodservice channels.

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

VANCOUVER, British Columbia, July 03, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) announced today that it will not be filing its annual financial statements, accompanying management's discussion and analysis and related chief executive officer ("CEO") and chief financial officer ("CFO") certifications for the financial year ended February 28, 2025 (collectively, the "Annual Filings"), within the period prescribed for the filing of such documents under Parts 4, 5 and 6 of National Instrument 51-102 Continuous Disclosure Obligations and pursuant to National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings, namely within 120 days of year-end, being June 30, 2025 (the "Filing Deadline").